{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:17:20Z","timestamp":1791296240445,"version":"4.1.0"},"reference-count":48,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,5,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>miRNA deregulation has been implicated in the pathogenesis of mantle cell lymphoma (MCL). Using a high-throughput quantitative real-time PCR platform, we performed miRNA profiling on cyclin D1\u2013positive MCL (n = 30) and cyclin D1\u2013negative MCL (n = 7) and compared them with small lymphocytic leukemia\/lymphoma (n = 12), aggressive B-cell lymphomas (n = 138), normal B-cell subsets, and stromal cells. We identified a 19-miRNA classifier that included 6 up-regulated miRNAs and 13 down regulated miRNA that was able to distinguish MCL from other aggressive lymphomas. Some of the up-regulated miRNAs are highly expressed in naive B cells. This miRNA classifier showed consistent results in formalin-fixed paraffin-embedded tissues and was able to distinguish cyclin D1\u2013negative MCL from other lymphomas. A 26-miRNA classifier could distinguish MCL from small lymphocytic leukemia\/lymphoma, dominated by 23 up-regulated miRNAs in MCL. Unsupervised hierarchical clustering of MCL patients demonstrated a cluster characterized by high expression of miRNAs from the polycistronic miR17-92 cluster and its paralogs, miR-106a-363 and miR-106b-25, and associated with high proliferation gene signature. The other clusters showed enrichment of stroma-associated miRNAs, and also had higher expression of stroma-associated genes. Our clinical outcome analysis in the present study suggested that miRNAs can serve as prognosticators.<\/jats:p>","DOI":"10.1182\/blood-2011-07-370122","type":"journal-article","created":{"date-parts":[[2012,4,6]],"date-time":"2012-04-06T05:49:59Z","timestamp":1333691399000},"page":"4939-4948","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":86,"title":["Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis"],"prefix":"10.1182","volume":"119","author":[{"given":"Javeed","family":"Iqbal","sequence":"first","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulei","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiling","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongfeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Lachel","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Deffenbacher","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Greiner","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Vose","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharathkumar","family":"Bhagavathi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Staudt","sequence":"additional","affiliation":[{"name":"Metabolism Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Rimsza","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Arizona, Tucson, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of W\u00fcrzburg, W\u00fcrzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Dr Margarete Fischer Bosch Institute of Clinical Pharmacology, Robert Bosch Hospital, Stuttgart, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Delabie","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[{"name":"Hospital Clinic, University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita M.","family":"Braziel","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Oregon Health and Science University, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Cook","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond R.","family":"Tubbs","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy D.","family":"Gascoyne","sequence":"additional","affiliation":[{"name":"Center for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James O.","family":"Armitage","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis D.","family":"Weisenburger","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"McKeithan","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing C.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111821323497500_B1","article-title":"International Agency for Research on Cancer.","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue","author":"Swerdlow","year":"2008"},{"issue":"1","key":"2019111821323497500_B2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era.","volume":"117","author":"P\u00e9rez-Gal\u00e1n","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2019111821323497500_B3","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1200\/JCO.2006.08.4251","article-title":"Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.","volume":"25","author":"Salaverria","year":"2007","journal-title":"J Clin Oncol"},{"issue":"12","key":"2019111821323497500_B4","first-page":"4365","article-title":"Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.","volume":"93","author":"Be\u00e0","year":"1999","journal-title":"Blood"},{"issue":"4","key":"2019111821323497500_B5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1200\/JCO.2008.16.8435","article-title":"Improvement of overall survival in advanced stage mantle cell lymphoma.","volume":"27","author":"Herrmann","year":"2009","journal-title":"J Clin Oncol"},{"issue":"12","key":"2019111821323497500_B6","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease.","volume":"101","author":"Orchard","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2019111821323497500_B7","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma.","volume":"70","author":"Fern\u00e0ndez","year":"2010","journal-title":"Cancer Res"},{"issue":"13","key":"2019111821323497500_B8","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1\u2013negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling.","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"},{"issue":"6","key":"2019111821323497500_B9","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood-2010-01-263806","article-title":"Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.","volume":"116","author":"Hartmann","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019111821323497500_B10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2141.2008.07443.x","article-title":"GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma.","volume":"144","author":"Vater","year":"2009","journal-title":"Br J Haematol"},{"issue":"13","key":"2019111821323497500_B11","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood-2009-09-243147","article-title":"microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.","volume":"115","author":"Zhao","year":"2010","journal-title":"Blood"},{"issue":"17","key":"2019111821323497500_B12","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1158\/0008-5472.CAN-09-1095","article-title":"MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas.","volume":"69","author":"Navarro","year":"2009","journal-title":"Cancer Res"},{"issue":"7","key":"2019111821323497500_B13","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/leu.2010.91","article-title":"Mantle cell lymphoma: transcriptional regulation by microRNAs.","volume":"24","author":"Di Lisio","year":"2010","journal-title":"Leukemia"},{"issue":"11","key":"2019111821323497500_B14","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1\u2013negative subtype.","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"},{"key":"2019111821323497500_B15","unstructured":"Simon\n              R\n            \n            \n              Peng\n              A\n            \n          \n          BRB-ArrayTools User Guide Version 4.2.0-Beta_1. Biometric Research Branch, National Cancer Institute.\n          Accessed February 2010\n          Available from: http:\/\/linus.nci.nih.gov\/BRB-ArrayTools.html"},{"issue":"12","key":"2019111821323497500_B16","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1002\/ijc.25284","article-title":"miR-145, miR-133a and miR-133b: Tumor suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.","volume":"127","author":"Kano","year":"2010","journal-title":"Int J Cancer"},{"issue":"2","key":"2019111821323497500_B17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.canlet.2011.04.005","article-title":"MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells.","volume":"307","author":"Noguchi","year":"2011","journal-title":"Cancer Lett"},{"issue":"10","key":"2019111821323497500_B18","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1158\/0008-5472.CAN-10-3568","article-title":"Human glioma growth is controlled by microRNA-10b.","volume":"71","author":"Gabriely","year":"2011","journal-title":"Cancer Res"},{"issue":"2","key":"2019111821323497500_B19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"issue":"6","key":"2019111821323497500_B20","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/labinvest.2009.26","article-title":"miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes.","volume":"89","author":"Tan","year":"2009","journal-title":"Lab Invest"},{"issue":"16","key":"2019111821323497500_B21","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1182\/blood-2008-10-184077","article-title":"Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas.","volume":"113","author":"Malumbres","year":"2009","journal-title":"Blood"},{"issue":"19","key":"2019111821323497500_B22","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1182\/blood-2008-09-178186","article-title":"Patterns of microRNA expression characterize stages of human B-cell differentiation.","volume":"113","author":"Zhang","year":"2009","journal-title":"Blood"},{"issue":"7163","key":"2019111821323497500_B23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature06174","article-title":"Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.","volume":"449","author":"Ma","year":"2007","journal-title":"Nature"},{"issue":"7311","key":"2019111821323497500_B24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature09284","article-title":"OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.","volume":"467","author":"Medina","year":"2010","journal-title":"Nature"},{"issue":"14","key":"2019111821323497500_B25","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1158\/0008-5472.CAN-08-0951","article-title":"Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer.","volume":"68","author":"Nagel","year":"2008","journal-title":"Cancer Res"},{"issue":"5","key":"2019111821323497500_B26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.stem.2010.02.017","article-title":"Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation.","volume":"6","author":"Liu","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2019111821323497500_B27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng.2007.30","article-title":"Widespread microRNA repression by Myc contributes to tumorigenesis.","volume":"40","author":"Chang","year":"2008","journal-title":"Nat Genet"},{"issue":"18","key":"2019111821323497500_B28","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1073\/pnas.0602266103","article-title":"Pre-B cell proliferation and lymphoblastic leukemia\/high-grade lymphoma in E(mu)-miR155 transgenic mice.","volume":"103","author":"Costinean","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2019111821323497500_B29","doi-asserted-by":"crossref","first-page":"E108","DOI":"10.1371\/journal.pbio.0020108","article-title":"Semi-supervised methods to predict patient survival from gene expression data.","volume":"2","author":"Bair","year":"2004","journal-title":"PLoS Biol"},{"key":"2019111821323497500_B30","article-title":"The miRNA-17-92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K\/AKT pathway activation [published online ahead of print November 25, 2011].","author":"Rao","journal-title":"Leukemia"},{"issue":"12","key":"2019111821323497500_B31","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1158\/0008-5472.CAN-06-4478","article-title":"Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia.","volume":"67","author":"Landais","year":"2007","journal-title":"Cancer Res"},{"issue":"1","key":"2019111821323497500_B32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cell.2007.07.021","article-title":"MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb.","volume":"131","author":"Xiao","year":"2007","journal-title":"Cell"},{"issue":"14","key":"2019111821323497500_B33","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1182\/blood-2009-02-204842","article-title":"Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma.","volume":"114","author":"Navarro","year":"2009","journal-title":"Blood"},{"issue":"15","key":"2019111821323497500_B34","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/sj.onc.1210856","article-title":"MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.","volume":"27","author":"Asangani","year":"2008","journal-title":"Oncogene"},{"issue":"24","key":"2019111821323497500_B35","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1182\/blood-2010-03-275925","article-title":"Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a.","volume":"116","author":"Lwin","year":"2010","journal-title":"Blood"},{"issue":"21","key":"2019111821323497500_B36","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med"},{"issue":"22","key":"2019111821323497500_B37","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas.","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111821323497500_B38","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","article-title":"Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.","volume":"115","author":"Iqbal","year":"2010","journal-title":"Blood"},{"issue":"9","key":"2019111821323497500_B39","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1073\/pnas.0308648100","article-title":"Activation of the Wnt signaling pathway in chronic lymphocytic leukemia.","volume":"101","author":"Lu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2019111821323497500_B40","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1182\/blood-2008-02-139212","article-title":"Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma.","volume":"112","author":"Gelebart","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111821323497500_B41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1074-7613(00)00004-2","article-title":"Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism.","volume":"13","author":"Reya","year":"2000","journal-title":"Immunity"},{"issue":"2","key":"2019111821323497500_B42","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4049\/jimmunol.167.2.765","article-title":"Wnt signaling regulates hemopoiesis through stromal cells.","volume":"167","author":"Yamane","year":"2001","journal-title":"J Immunol"},{"issue":"5","key":"2019111821323497500_B43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1535-6108(03)00268-X","article-title":"Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue.","volume":"4","author":"Liang","year":"2003","journal-title":"Cancer Cell"},{"issue":"7","key":"2019111821323497500_B44","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1182\/blood-2011-07-369199","article-title":"The canonical Wnt pathway shapes niches supportive for hematopoietic stem\/progenitor cells.","volume":"119","author":"Ichii","year":"2012","journal-title":"Blood"},{"issue":"12","key":"2019111821323497500_B45","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1158\/0008-5472.CAN-10-0659","article-title":"Myc-induced microRNAs integrate Myc-mediated cell proliferation and cell fate.","volume":"70","author":"Kim","year":"2010","journal-title":"Cancer Res"},{"issue":"30","key":"2019111821323497500_B46","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1200\/JCO.2007.12.0410","article-title":"Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue.","volume":"26","author":"Hartmann","year":"2008","journal-title":"J Clin Oncol"},{"issue":"10","key":"2019111821323497500_B47","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ncb2105","article-title":"A Pumilio-induced RNA structure switch in p27-3\u2032 UTR controls miR-221 and miR-222 accessibility.","volume":"12","author":"Kedde","year":"2010","journal-title":"Nat Cell Biol"},{"issue":"6","key":"2019111821323497500_B48","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1084\/jem.20101823","article-title":"miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice.","volume":"208","author":"Boldin","year":"2011","journal-title":"J Exp Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/21\/4939\/1351763\/zh802112004939.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/21\/4939\/1351763\/zh802112004939.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T02:32:52Z","timestamp":1574130772000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/21\/4939\/29919\/Genomewide-miRNA-profiling-of-mantle-cell-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,24]]},"references-count":48,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2012,5,24]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-07-370122","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,24]]}}}